----
About

Medtide Inc.
03880.HK
Medtide Inc., a contract research, development, and manufacturing company, provides early-stage discovery, pre-clinical research, clinical development, and commercial-stage production services. It offers peptide new chemical entity discovery synthesis, manufacturing, and control development and commercial manufacturing services. The company focuses on developing oral and/or injectable glucagon, such as peptide-1 (GLP-1) molecule products. Its research and development technology platforms include OmniPeptSynth, PeptiConjuX, PeptiNuclide LinkTech, GreenSynth Innovations, and Impurity Screening.
Profile
- Company Name
- Medtide Inc.
- Market
- SEHK
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- www.medtideinc.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
